Aphios
  • Technology
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      • CFN
        • CFN Techniques
      • PNS
        • PNS Characteristics
      • PNP
        • PNP Impacts
    • Drug Safety
      • CFI Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
  • Products
    • Enhanced Therapeutic Products Overview
    • Therapeutic Product Pipeline
      • Oncology
        • Zindol
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes
        • Camposomes
        • Dermos
        • APH-0201
        • Sperol
      • Infectious Disease
        • APH-0812
        • APH-0202
        • nanoHYP
        • Asterias
        • Marinus
        • HIV-AIDS Therapeutic Vaccine
          • CFI HIV Vaccine
        • Anti-HIV
        • Anti-Influenza
        • Vaccine Adjuvant Technology
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        • APH-1104
        • Xantol
        • APH-0802
        • APH-1403
      • Diabetes
        • APH-0907
    • Research Chemicals
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine
      • Cyclopamine
      • Cycloposine
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol
      • 8-Gingerol
      • 10-Gingerol
      • Hypericin
      • Hyperforin
      • Hyperforin DCHA
      • Jervine
      • MLA
      • Muldamine
      • Nobiletin
      • Paclitaxel
      • Phloridzin Dihydrate
      • Sclareolide
      • 6-Shogaol
      • Tangeretin
      • Veratramine
    • Equipment
    • QOL Medicines
  • Partners
    • Partnering Overview
      • Zindol LLC
    • Pharmaceutical & Biotechnology Partners
    • Institutional Research Partners
    • University Partners
    • Partnering Contact Us
  • Resource Center
    • Overview
    • Facilities
    • Intellectual Property
    • Marine Microorganism Library
    • Research Grants & Contracts
    • Publications/Articles
    • Presentations
    • White Papers
    • Video Library
  • News & Current Events
    • Current Events
    • Press Releases and News
      • Press Releases Archive
        • 2012 Press Releases
        • 2011 Press Releases
        • 2010 Press Releases
        • 2009 Press Releases
        • 2008 Press Releases
        • 2007 Press Releases
        • 2006 Press Releases
        • 2005 Press Releases
        • 2004 Press Releases
        • 2003 Press Releases
        • 2002 Press Releases
        • 2001 Press Releases
        • 2000 Press Releases
        • 1999 Press Releases
        • 1998 Press Releases
  • About Us
    • Company Overview
    • Management and Directors
    • Scientific Advisory Board
    • Investors
    • Community Involvement
    • Connect with Aphios
    • Careers
    • Contact Us
  • Home
News & Events (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a ,m) })(window,document,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-56868145-1', 'auto'); ga('send', 'pageview');
  • Current Events
  • Press Releases and News
    • Press Releases Archive
      • 2012 Press Releases
      • 2011 Press Releases
      • 2010 Press Releases
      • 2009 Press Releases
      • 2008 Press Releases
      • 2007 Press Releases
      • 2006 Press Releases
      • 2005 Press Releases
      • 2004 Press Releases
      • 2003 Press Releases
      • 2002 Press Releases
      • 2001 Press Releases
      • 2000 Press Releases
      • 1999 Press Releases
      • 1998 Press Releases
September 09, 2003

Aphios Executes Cooperative Agreement with NIH & USAMRID for Discovery of Novel SARS Therapeutics

June 03, 2003

Aphios Corporation Granted United States Patent for Fractionation of Biologically Derived Materials

September 07, 2003

Aphios Corporation Awarded National Institutes of Health Grant for Development of Novel Anti-Influenza Drugs

Aphios Inspired by Nature, Enabled by Science™
  • Contact Us
  • Careers
  • Investors
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
  • © 2012 All rights reserved
  • Site Map
  • Privacy Policy
  • Contact Us